Want to join the conversation?
$DY posted improved earnings in 4Q16, helped by higher revenues compared to 4Q15. Net income was $49.4MM or $1.54 per common diluted share compared to $33.8MM or $0.97 per common diluted share last year. Contract revenues were $789.2MM in 4Q16, compared to $578.5MM in 4Q15. Non-GAAP adjusted net income was $52.7MM or $1.64 per common share diluted.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?